These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 14613737
1. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Herreros J, Prósper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sánchez PL, Cañizo C, Rábago G, Martí-Climent JM, Hernández M, López-Holgado N, González-Santos JM, Martín-Luengo C, Alegria E. Eur Heart J; 2003 Nov; 24(22):2012-20. PubMed ID: 14613737 [Abstract] [Full Text] [Related]
2. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. Gavira JJ, Herreros J, Perez A, Garcia-Velloso MJ, Barba J, Martin-Herrero F, Cañizo C, Martin-Arnau A, Martí-Climent JM, Hernández M, López-Holgado N, González-Santos JM, Martín-Luengo C, Alegria E, Prósper F. J Thorac Cardiovasc Surg; 2006 Apr; 131(4):799-804. PubMed ID: 16580437 [Abstract] [Full Text] [Related]
3. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kurpisz M. Am Heart J; 2004 Sep; 148(3):531-7. PubMed ID: 15389244 [Abstract] [Full Text] [Related]
4. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Dib N, McCarthy P, Campbell A, Yeager M, Pagani FD, Wright S, MacLellan WR, Fonarow G, Eisen HJ, Michler RE, Binkley P, Buchele D, Korn R, Ghazoul M, Dinsmore J, Opie SR, Diethrich E. Cell Transplant; 2005 Sep; 14(1):11-9. PubMed ID: 15789658 [Abstract] [Full Text] [Related]
5. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW. J Am Coll Cardiol; 2003 Dec 17; 42(12):2063-9. PubMed ID: 14680727 [Abstract] [Full Text] [Related]
6. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Hagège AA, Carrion C, Menasché P, Vilquin JT, Duboc D, Marolleau JP, Desnos M, Bruneval P. Lancet; 2003 Feb 08; 361(9356):491-2. PubMed ID: 12583951 [Abstract] [Full Text] [Related]
10. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor. Gmeiner M, Zimpfer D, Holfeld J, Seebacher G, Abraham D, Grimm M, Aharinejad S. J Thorac Cardiovasc Surg; 2011 May 08; 141(5):1238-45. PubMed ID: 21329947 [Abstract] [Full Text] [Related]
12. Association of electrostimulation with cell transplantation in ischemic heart disease. Shafy A, Lavergne T, Latremouille C, Cortes-Morichetti M, Carpentier A, Chachques JC. J Thorac Cardiovasc Surg; 2009 Oct 08; 138(4):994-1001. PubMed ID: 19660354 [Abstract] [Full Text] [Related]
16. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. Yerebakan C, Kaminski A, Westphal B, Donndorf P, Glass A, Liebold A, Stamm C, Steinhoff G. J Thorac Cardiovasc Surg; 2011 Dec 08; 142(6):1530-9.e3. PubMed ID: 21664627 [Abstract] [Full Text] [Related]
17. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. Ince H, Petzsch M, Rehders TC, Chatterjee T, Nienaber CA. J Endovasc Ther; 2004 Dec 08; 11(6):695-704. PubMed ID: 15615560 [Abstract] [Full Text] [Related]